FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Tris Pharma Infants' Ibuprofen Recall

Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1

Tris Pharma Inc. · Monmouth Junction, NJ

Risk level
Class II
Reported by FDA
Feb 20, 2019
Recall ID
D-0493-2019
Check your lot numberHow we source this data

Summary

Tris Pharma recalled Infants' Ibuprofen starting Jan 15, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0493-2019 on Feb 20, 2019. Reason: Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled. Status: Terminated.

Why it was recalled

Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

Product description

Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 39338 3, NDC 59779-925-23.

Lot numbers, UPCs & expiration codes

Lot#: 4718, Exp 12/19

Where it was sold

One distributor who further distributed Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0493-2019
Classification
Class II
Status
Terminated
Recall initiated
Jan 15, 2019
FDA report date
Feb 20, 2019
Quantity
46,080 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Tris Pharma Inc.

Original FDA data

Every field from FDA enforcement report D-0493-2019, exactly as published.

Show all FDA fields
City
Monmouth Junction
State
NJ
Status
Terminated
Country
United States
Event ID
81960
Address
2033 US Highway 130
Code information
Lot#: 4718, Exp 12/19
Postal code
08852-3003
Report date
Feb 20, 2019
Product type
Drugs
Recall number
D-0493-2019
Classification
Class II
Recalling firm
Tris Pharma Inc.
Product quantity
46,080 bottles
Termination date
Mar 29, 2023
Reason for recall
Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 39338 3, NDC 59779-925-23.
Distribution pattern
One distributor who further distributed Nationwide in the USA.
Recall initiation date
Jan 15, 2019
Initial firm notification
Letter
Center classification date
Feb 14, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0493-2019, published Feb 20, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls